Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone)

International Journal of Gynecology and Obstetrics

Volumn 114, Issue 2, 2011, Pages 145-148

  Mohamed, Ahmed M M ^a   El Sherbiny, Wael S M ^a   Mostafa, Walaa A I ^a  

^a Cairo University   (Egypt)

Author keywords

Combined contraceptive vaginal ring; Combined oral contraceptive; Cycle control; Metabolic effects

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DROSPIRENONE PLUS ETHINYLESTRADIOL; GLUCOSE; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACNE; ADOLESCENT; ADULT; ANTICOAGULATION; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; BODY WEIGHT; BREAKTHROUGH BLEEDING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG INDUCED HEADACHE; DYSMENORRHEA; ENZYME ACTIVITY; FEMALE; FEMALE CONTRACEPTIVE DEVICE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; INTERMETHOD COMPARISON; LEUKORRHEA; LIBIDO DISORDER; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MASTALGIA; MENSTRUAL CYCLE; MENTAL INSTABILITY; NAUSEA; OPEN STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; VAGINA RING; VAGINITIS; VOMITING;

EID: 79960157334     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2011.03.008     Document Type: Article

References (20)

1. M.J. Rosenberg, A. Meyers, and V. Roy Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations Contraception 60 6 1999 321 329 (Pubitemid 30133220)
2. R.D. Blackburn, A. Cunkelman, and V.M. Zlidar Oral contraceptives - an update Popul Rep A 28 1 2000 1 16 25-32
3. I. Milsom, I. Lete, A. Bjertnaes, K. Rokstad, I. Lindh, and C.J. Gruber Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone Hum Reprod 21 9 2006 2304 2311 (Pubitemid 44530604)
4. D. Shoupe, and S.L. Kjos Current Clinical Practice: The Handbook of Contraception: A Guide for Practical Management 1st edition 2006 Humana Press Totowa, NJ
5. T.O. Dieben, F.J. Roumen, and D. Apter Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring Obstet Gynecol 100 3 2002 585 593 (Pubitemid 35246150)
6. C.J. Timmer, D. Apter, and G. Voortman Pharmacokinetics of 3-keto-desogestrel and ethinylestradiol released from different types of contraceptive vaginal rings Contraception 42 6 1990 629 642
7. S. Killick Complete and robust ovulation inhibition with NuvaRing Eur J Contracept Reprod Health Care 7 Suppl. 2 2002 13 18 (Pubitemid 36269615)
8. A. Novák, C. de la Loge, L. Abetz, and E.A. van der Meulen The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability Contraception 67 3 2003 187 194 (Pubitemid 36255655)
9. S. Veres, L. Miller, and B. Burington A comparison between the vaginal ring and oral contraceptives Obstet Gynecol 104 3 2004 555 563 (Pubitemid 40458845)
10. F. Roumen Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing Eur J Contracept Reprod Health Care 7 Suppl. 2 2002 19 24 (Pubitemid 36269616)
11. F.J. Roumen, D. Apter, T.M. Mulders, and T.O. Dieben Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol Hum Reprod 16 3 2001 469 475 (Pubitemid 32218795)
12. M.W. van den Heuvel, A.J. van Bragt, A.K. Alnabawy, and M.C. Kaptein Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive Contraception 72 3 2005 168 174 (Pubitemid 41133355)
13. H.J. Ahrendt, I. Nisand, C. Bastianelli, M.A. Gómez, K. Gemzell-Danielsson, and W. Urdl Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone Contraception 74 6 2006 451 457 (Pubitemid 46043314)
14. R. Sabatini, and R. Cagiano Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives Contraception 74 3 2006 220 223 (Pubitemid 44175362)
15. F.J. Roumen Review of the combined contraceptive vaginal ring, NuvaRing Ther Clin Risk Manag 4 2 2008 441 451 (Pubitemid 351712002)
16. K.J. O'Connell, L.M. Osborne, and C. Westhoff Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive Contraception 72 5 2005 323 327 (Pubitemid 41503126)
17. K. Oddsson, B. Leifels-Fischer, N.R. de Melo, D. Wiel-Masson, C. Benedetto, and C.H. Verhoeven Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial Contraception 71 3 2005 176 182 (Pubitemid 40250198)
18. F.J. Roumen, and T.O. Dieben Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive Fertil Steril 85 1 2006 57 62 (Pubitemid 43063423)
19. M. Tuppurainen, R. Klimscheffskij, M. Venhola, and T.O. Dieben The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study Contraception 69 5 2004 389 394 (Pubitemid 38510329)
20. E.M. Magnusdóttir, R.I. Bjarnadóttir, P.T. Onundarson, B.R. Gudmundsdóttir, R.T. Geirsson, and S.D. Magnusdóttir The contraceptive vaginal ring (NuvaRing) and hemostasis: a comparative study Contraception 69 6 2004 461 467 (Pubitemid 38638746)